Tag: FDA exclusivity
Patent Exclusivity vs Market Exclusivity: What’s the Real Difference for Drug Prices?
Patent exclusivity and market exclusivity are two different legal tools that protect new drugs. One comes from the patent office, the other from the FDA. Understanding the difference explains why drug prices stay high-and who controls when generics arrive.
read morerecent posts
Learn how absolute and relative risk numbers in drug ads can mislead you. See why 50% risk reduction might mean just a 1% real change - and how to ask the right questions to make smarter health choices.
Published ON: 5 JanOpioids in older adults increase fall risk, trigger delirium, and can be deadly at standard doses. Learn why lower doses, careful monitoring, and non-drug options are critical for safe pain management in seniors.
Published ON: 4 JanTurmeric and curcumin supplements can dangerously increase bleeding risk when taken with blood thinners like warfarin or aspirin. Real cases show INR levels spiking to life-threatening levels. Avoid combining them without medical supervision.
Published ON: 19 JanPatent expiry means cheaper drugs-but only if you're prepared. Learn how patients and healthcare systems can save money and avoid disruptions when brand-name drugs go generic.
Published ON: 12 JanTurmeric and curcumin supplements can dangerously increase bleeding risk when taken with blood thinners like warfarin or aspirin. Real cases show INR levels spiking to life-threatening levels. Avoid turmeric supplements if you're on anticoagulants.
Published ON: 19 Jan